Global Staphylococcal Infection Drugs Market 2019-2023 | Improved Screening of Antibiotic-Resistant Strains to Boost Growth | Technavio

LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Biotechnology?src=hash" target="_blank"gt;#Biotechnologylt;/agt;–The global staphylococcal infection drugs market is expected to post a
CAGR of close to 3% during the period 2019-2023, according to the latest
market research report by Technavio.

A key factor driving the growth of the global staphylococcal infection
drugs market is the rise in the use of antibiotics. Antibiotics have
become an ideal option for the treatment of infectious diseases, as it
has the potential to kill or inhibit the growth of a disease-causing
microorganism. As a result, they are extensively being used for the
treatment of infectious diseases including staphylococcal infections.
Further, the growing consumption of antibiotics is attributed to its
affordability and the rapid economic growth in countries such as China,
India, and Pakistan. Such growth in the global consumption of
antibiotics will directly impact market growth during the forecast
period.

As per Technavio, the improved screening of antibiotic-resistant strains
will have a positive impact on the market and contribute to its growth
significantly over the forecast period. This global
staphylococcal infection drugs market 2019-2023
research report also analyzes other important trends and
market drivers that will affect market growth over 2019-2023.

Global staphylococcal infection drugs market:
Improved screening of antibiotic-resistant strains

With the growing advances in molecular and cell biology, there has been
a significant improvement in screening methodologies, particularly for
the detection of antibiotic-resistant strains. The electro-chemical
phenotyping approach is one of the emerging methodologies for the
detection of antibiotic resistance bacteria, that utilizes a
microfluidic chip in which the bacteria are incubated with various
antibiotics. Another highly advanced screening methodology involves
high-throughput diagnostic arrays, which help in the detection of
antimicrobial resistance in Gram-positive as well as Gram-negative
bacteria. These technologies are allowing the rapid screening of rare
antibiotic-resistant mutants, which further aid in the identification
and the development of novel drugs.

“Although antibiotics are the only available options for the
treatment of staphylococcal infections, a number of manufacturers are
investing in the development of novel drugs such as monoclonal
antibodies and vaccines. Monoclonal antibodies are currently being
evaluated for their efficacy to treat the staphylococcal infection. Such
developments in the treatment for the staphylococcal infection will fuel
the market growth during the forecast period,” says a senior
research analyst at Technavio.

Global staphylococcal infection drugs market:
Segmentation analysis

This market research report segments the global staphylococcal infection
drugs market by product (beta-lactams, peptides, quinolones, macrolides,
and others) and geographic regions (North America, Europe, Asia, and
ROW).

The Asian region led the market in 2018, followed by ROW, North America,
and Europe respectively. The market growth in Asia can be attributed to
the increased use of antibiotics in emerging economies including China
and India. The introduction of national guidelines and the establishment
of surveillance networks for antibiotic use by the Chinese government
has led to a rise in antibiotic consumption.

Looking for more information on this market? Request
a free sample report

Technavio’s sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

• Market ecosystem
• Market characteristics
• Market segmentation analysis

Market Sizing

• Market definition
• Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

• Regional comparison
• Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Competitive scenario

About Technavio

Technavio
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio’s comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team
at [email protected].

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US:
+1 844 364 1100
UK: +44 203 893 3200
www.technavio.com